India’s Cipla beats Q2 profit view on strong US, India demand

Oct 29 (Reuters) – Cipla (CIPL.NS), opens new tab, India’s third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, driven by higher sales of its …